View:

Top Stock Losers

Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.

Related Articles

Featured Article
Why Shares of DBV Technologies Jumped Thursday
Jim Halley | May 11, 2023
"The New England Journal of Medicine" reported phase 3 trial details regarding the company's peanut allergy treatment for toddlers.
Young patient in hospital bed
Why DBV Technologies Stock Is Soaring Today
Keith Speights | Dec 23, 2022
The company can now move forward with a late-stage study of its lead pipeline candidate.
Peanut held by girl
Why DBV Technologies Stock Popped Again Today
Eric Volkman | Jun 9, 2022
The French biotech kept its upward momentum going with news of nearly $200 million in fresh funding.
Two people seated at a lab desk featuring a PC screen and microscope
Why DBV Technologies Was a Big Winner on Wednesday
Eric Volkman | Jun 8, 2022
Its peanut allergy patch tests quite well in very young patients.
download
Kuke Music Holding Limited (KUKE) Q1 2022 Earnings Call Transcript
Motley Fool Transcribing | May 26, 2022
KUKE earnings call for the period ending March 31, 2022.
featured-transcript-logo
Kuke Music Holding Limited (KUKE) Q4 2021 Earnings Call Transcript
Motley Fool Transcribing | Mar 16, 2022
KUKE earnings call for the period ending December 31, 2021.
featured-transcript-logo
Why DBV Technologies Stock Is Down Sharply on Tuesday
Cory Renauer | Dec 21, 2021
The road ahead for the peanut allergy treatment Viaskin Peanut is going to be rockier than investors had hoped.
unhappy-investor-checking-stocks-getty
Kuke Music Holding Limited (KUKE) Q3 2021 Earnings Call Transcript
Motley Fool Transcribing | Nov 29, 2021
KUKE earnings call for the period ending September 30, 2021.
featured-transcript-logo
Why DBV Technologies Stock Is Jumping Today
Keith Speights | Nov 1, 2021
The company plans to announce new data for its experimental peanut allergy drug this week.
Peanut allergy - young boy
Kuke Music Holding Limited (KUKE) Q2 2021 Earnings Call Transcript
Motley Fool Transcribing | Aug 6, 2021
KUKE earnings call for the period ending June 30, 2021.
featured-transcript-logo